A Simple Observational study looking for similarities between biomarkers in the blood and the amount of amyloid plaque seen in the brain.  

Amyvid is indicated for PET imaging of the brain to estimate amyloid plaque density in adult patients with cognitive impairment who are being evaluated for AD and other causes of cognitive decline. Amyvid is an adjunct to other diagnostic evaluations.

• PET scan provided at no cost and results will be provided
• You must be 60 to 80 years old and have mild cognitive impairment.
• Participation will be limited to June and July of 2022